Significant changes in the payment system in England expected from April 2021

19

Mar 2021

NHS England and Improvement (NHSEI) is currently developing National Tariff Payment System (NTPS) for 2021/22. In November 2020, NHSEI released the 2021/22 Tariff engagement document and initiated a feedback survey.

According to this document, the main change expected from April 2021 is introducing a consistent blended payment approach across almost all specialist healthcare services, including both the acute and non-acute sectors, in line with the NHS Long Term Plan (LTP) objective of moving to population-based funding. This would greatly broaden the scope of blended payments and would replace the individual service-level blended payments introduced in previous tariffs.

The blended payment model for 2021/22 would include a fixed payment based on the costs of delivering a level of activity that conforms to the Integrated Care System (ICS) plan and a variable element for some elective activity.

Alongside the blended payment arrangements, providers and commissioners would need to sign up a System Collaboration and Financial Management Agreement (SCFMA) under the terms of the NHS Standard Contract. The SCFMA would serve to share financial risk across the system.

Implementing the blended payment arrangements would have a significant impact on the operation of the NTPS. While NHSEI will continue to calculate and publish prices, the majority of these would be unit prices for services outside the scope of blended payment rather than national (i.e., mandated) prices.

See the full details here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

The latest related news

21

Mar 2022

The NHS Insights Prioritisation Programme (NIPP) is commissioned by the NHS Accelerated Access Collaborative (AAC) and the National Institute for Health Research (NIHR). It is designed to accelerate the evaluation and implementation of innovation that supports post-pandemic ways of working, builds service resilience, and delivers benefits to patients. Fourteen projects have been funded and have now commenced activity that will be ongoing until March 2023.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more